Pacific Biosciences Of California (PACB) Return on Equity [ROE] (2011 - 2026)
Pacific Biosciences Of California's Return on Equity [ROE] was -3333.14% in Q1 2026, down 3113.25 percentage points from -219.90% a year earlier and down 696.13 percentage points from the prior quarter.
Powered by 
Analysis
Pacific Biosciences Of California (PACB) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Pacific Biosciences Of California came in at -213.45%, down 162.15 percentage points from FY2024.
- Return on Equity [ROE] has now declined for five consecutive years, with a five-year change of -228.51 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -51.30% in FY2024 (-2.78 pp), -48.53% in FY2023 (-2.10 pp), -46.42% in FY2022 (-14.25 pp) and -32.18% in FY2021 (-47.24 pp).
- The Q1 2026 figure marks the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
- Compared with a year earlier, Return on Equity [ROE] has declined for eight straight quarters, with an average year-over-year change of -939.03 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2021 (a gain of 194.64 percentage points); the worst was Q1 2026 (a drop of 3113.25 percentage points).
- Per Business Quant data, PACB's Return on Equity [ROE] in the three quarters before Q1 2026 was -2637.01% (Q4 2025), -1032.26% (Q3 2025) and -687.48% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 13.36% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 10.39% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 7.56% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 17.60% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 10.44% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | -3.90% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 14.31% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 9.53% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 3.88% |
| 10 | Pacific Biosciences Of California | 736.62 Mn | -354.38 Mn | 12.64 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -3,333.14% |
| Dec 31, 2025 | -2,637.01% |
| Sep 30, 2025 | -1,032.26% |
| Jun 30, 2025 | -687.48% |
| Mar 31, 2025 | -219.90% |
| Dec 31, 2024 | -64.57% |
| Sep 30, 2024 | -83.36% |
| Jun 30, 2024 | -70.14% |
| Mar 31, 2024 | -43.97% |
| Dec 31, 2023 | -41.87% |
| Sep 30, 2023 | -43.98% |
| Jun 30, 2023 | -47.85% |
| Mar 31, 2023 | -51.12% |
| Dec 31, 2022 | -52.84% |
| Sep 30, 2022 | -45.73% |
| Jun 30, 2022 | -29.04% |
| Mar 31, 2022 | -23.00% |
| Dec 31, 2021 | -15.87% |
| Sep 30, 2021 | 2.70% |
| Jun 30, 2021 | -9.44% |
API Access
Pacific Biosciences Of California Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PACB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PACB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PACB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();